Skip to main content
. 2022 Sep 28;77(5):1349–1358. doi: 10.1016/j.jhep.2022.07.036

Table 3.

Predictors of COVID-19 after full vaccination among participants who received 3 vs. 2 doses of an mRNA vaccine.

Number of events
Number of events: COVID-19 severity based on chart review
COVID-19
Symptomatic
Moderate + severe + critical
Severe + critical
aHR (95% CI) p value aHR (95% CI) p value aHR (95% CI) p value aHR (95% CI) p value
Total number of patients 26,082 26,082 26,082 26,082
Number of events 68 55 18 7
 2 Dose mRNA vaccine 57 (0.44%) 46 (0.35%) 15 (0.12%) 7 (0.05%)
 3 Dose mRNA vaccine 11 (0.08%) 9 (0.07%) 3 (0.02%) 0 (0.00%)
Vaccine
 2 Dose mRNA vaccine REF REF REF REF
 3 Dose mRNA vaccine 0.19 (0.10–0.36) <0.0001 0.19 (0.09–0.39) <0.0001 0.20 (0.06–0.70) 0.0113 0.00 (0.00–0.00) <0.0001
Age 1.03 (0.99–1.06) 0.1128 1.02 (0.99–1.06) 0.2007 1.07 (1.02–1.12) 0.0058 1.07 (1.01–1.13) 0.0193
Race other than non-Hispanic white 1.51 (1.29–1.88) 0.0150 1.55 (0.31–2.01) 0.0905 1.35 (0.10–2.20) 0.0946 1.30 (0.35–2.54) 0.2677
Alcohol-associated cirrhosis 1.15 (0.55–1.62) 0.8387 1.13 (0.51–1.70) 0.8131 1.54 (0.18–2.58) 0.2575 1.36 (0.14–2.12) 0.2251
Diabetes 1.30 (0.80–2.11) 0.2852 1.33 (0.77–2.28) 0.3035 2.80 (0.88–8.92) 0.0815 1.98 (0.83–11.81) 0.4546
Current/former smoker 1.84 (0.51–2.37) 0.4774 1.84 (0.49–2.44) 0.5190 1.89 (0.33–2.41) 0.8170 1.83 (0.43–2.61) 0.9667
Cirrhosis comorbidity
 0 REF REF REF REF
 1+0 1.34 (0.11–2.03) 0.0574 1.23 (0.06–1.89) 0.0330 n.a. n.a. n.a. n.a.
 1+1 1.78 (0.78–4.06) 0.1696 1.54 (0.65–3.64) 0.3217 2.44 (0.52–11.47) 0.2599 2.35 (0.23–24.37) 0.4736
 3+0 1.35 (0.43–4.21) 0.6058 1.56 (0.49–4.98) 0.4558 2.85 (0.45–17.95) 0.2644 1.97 (0.13–30.07) 0.6261
 3+1 1.91 (0.40–3.10) 0.8307 1.92 (0.39–3.15) 0.8393 1.09 (0.21–5.70) 0.9227 n.a. n.a.
eCTP class
 A REF REF REF REF
 B or C 1.58 (0.88–2.85) 0.1267 1.48 (0.75–2.93) 0.2547 1.04 (0.31–3.49) 0.9468 1.14 (0.34–4.04) 0.9929

Values in bold denote statistical significance.

Statistical method/test applied: Cox proportional-hazards model.

References were: race (non-Hispanic white); no alcohol-associated cirrhosis; no diabetes; non-smoker/former smoker.

aHR, adjusted hazard ratio; eCTP, electronic Child-Turcotte-Pugh.